Drug Trial Radar · NCT03771664
A Study to Evaluate the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Participants With Comorbid Major Depressive Disorder (MDD) and Insomnia
Last checked: Nov 20, 2026Latest source record: Nov 29, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
87
Actual
Start
Feb 4, 2019
Primary completion
Dec 20, 2019
Study completion Jan 17, 2020
Sponsor
- Lead sponsor
- BiogenBiogen (BIIB)
- Sponsor type
- Industry
- First posted
- Dec 11, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a randomized, double-blind, placebo-controlled study of the safety, tolerability, and efficacy of SAGE-217 compared to placebo in adult participants with comorbid major depressive disorder (MDD) and insomnia.
Conditions
- Major Depressive Disorder
- Insomnia
Interventions
SAGE-217Drug
Administered as capsules.
PlaceboDrug
Administered as capsules.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Average Change From Baseline in Sleep Efficiency (SE) as Assessed by Polysomnogram (PSG) at Days 13 and 14Time frame: Baseline and Days 13, 14
Locations
28 sites in 1 country. Site status is shown where the registry gives one.
Sage Investigational Site
Little Rock, Arkansas
Sage Investigational Site
Rogers, Arkansas
Sage Investigational Site
Garden Grove, California
Sage Investigational Site
Oceanside, California
Sage Investigational Site
San Diego, California
Sage Investigational Site
Temecula, California
Sage Investigational Site
Fort Myers, Florida
Sage Investigational Site
Hollywood, Florida
Sage Investigational Site
Miami Lakes, Florida
Sage Investigational Site
North Miami, Florida
Sage Investigational Site
Atlanta, Georgia
Sage Investigational Site
Atlanta, Georgia
Sage Investigational Site
Decatur, Georgia
Sage Investigational Site
Chicago, Illinois
Sage Investigational Site
Lake Charles, Louisiana
Sage Investigational Site
Flowood, Mississippi
Sage Investigational Site
St Louis, Missouri
Sage Investigational Site
Las Vegas, Nevada
Sage Investigational Site
Berlin, New Jersey
Sage Investigational Site
Albuquerque, New Mexico
Sage Investigational Site
Brooklyn, New York
Sage Investigational Site
New York, New York
Sage Investigational Site
Cincinnati, Ohio
Sage Investigational Site
Dayton, Ohio
Sage Investigational Site
Oklahoma City, Oklahoma
Sage Investigational Site
Salem, Oregon
Sage Investigational Site
Charleston, South Carolina
Sage Investigational Site
Austin, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.